Discussion on: Epigenetic Modifiers as Therapeutic Targets at the Interface of Infectious Diseases and Cancer Progression

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title

Epigenetic Modifiers as Therapeutic Targets at the Interface of Infectious Diseases and Cancer Progression

Authored by

Ogechi Cecilia Ofor
Department of Biomedical Sciences, Ebonyi State University, Nigeria.

Joseph Adaviruku Sanni
Department of Chemoinformatics and Bioengineering, Centre for Chemical Sciences, ITMO University, Russia and Department of Neuropharmacology, Institute of Experimental Medicine, Russia.

Augusta Imomon
University of Nigeria, Nigeria and University of Cote d’Azur, France.

Juliana Ojonugwa Ocheni
University of Port Harcourt, Nigeria.

Quadri O. Adewuyi
University of Missouri Kansas City, Missouri, USA.

Ekaba Samson Gift
Department of Biological Sciences, Kogi State University, Nigeria.

Sandra Ngozika Offor
Department of Cell and Molecular Biology, Tulane University, Louisiana, USA.

Odeyemi Aduragbemi
Ladoke Akintola University of Technology, Nigeria.

Sonay Unsal
St James School of Medicine, USA.

Yakubu Bitrus
Alpha Higher Institute of Biomedical and Technological Science, Douala, Cameroon.

Ijibadejo Margaret Seun
Department of Biochemistry, Babcock University, Ilishan Remo Ogun State, Nigeria.

Possible Okikiola Popoola
Department of Nanobiotechnology Engineering, Universiti Malaysia Perlis, Malaysia.

DOI or Article Link

https://doi.org/10.9734/aorj/2026/v9i1127

Leave a Comment